We are very happy to share that the story of the discovery of MBL-AB01 finally has been published in Applied and Environmental Microbiology. MBL-AB01 is a novel antibacterial xanthone antibiotic displaying high activity against methicillin-resistant Staphylococcus aureus. The compound...
Read MoreRG Discovery is committed to sustainability, increasing our knowledge and decreasing our environmental impact step by step. We always aim to improve our operations to make them as green as possible. Our collaboration with the Swedish site of the...
Read More9th Fragment-based Drug Discovery – RSC BMCS Red Glead Discovery is attending the 9th RSC-BMCS Fragment-based Drug Discovery meeting. The meeting will focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry,...
Read MoreTogether with ShareLab, Oslo, Red Glead Discovery is organizing a Half-Day Seminar with Breakfast and a Competition: “Transforming research results into a drug development company” At this seminar we will dive into inspiring case studies of turning academic research...
Read More